Average surface temperatures of the Black Sea may not have risen, according to the surprising results of a new study from the JRC.
articles
Heather Kulik: Innovative modeling for chemical discovery
Without setting foot from her office, Heather Kulik, the Joseph R. Mares '24 Career Development Assistant Professor of Chemical Engineering, is charting unknown worlds. Her discoveries plumb “vast regions of chemical space,” she says, a domain comprised of combinations of chemical elements that do not yet exist. “Best estimates indicate that we have likely made or studied only about 1 part in 10 to the 50th of that chemical space,” she says.
New Model May Help Overcome the Brain's Fortress-Like Barrier
Scientists have helped provide a way to better understand how to enable drugs to enter the brain and how cancer cells make it past the blood brain barrier.
Exposure to Pet and Pest Allergens During Infancy Linked to Reduced Asthma Risk
Children exposed to high indoor levels of pet or pest allergens during infancy have a lower risk of developing asthma by 7 years of age, new research supported by the National Institutes of Health reveals. The findings, published September 19 in the Journal of Allergy and Clinical Immunology, may provide clues for the design of strategies to prevent asthma from developing.
Special Protection for Area Exposed by Larsen C Iceberg
An international agreement is now in place to give special protection to the area of ocean left exposed when one of the largest icebergs ever recorded broke free from the Larsen C Ice Shelf in July this year. The iceberg – known as A68 – is starting to move north, and it will leave behind a 5,818 km2 area of seabed exposed to open marine conditions. Much of this area may have been ice-covered since the last inter-glacial period around 120,000 years ago, providing a unique opportunity for scientists to study how marine life responds to this dramatic change.
Scientists Discover Genetic Markers for Severe Form of Multiple Sclerosis
Scientists have uncovered two related cytokines and associated genetic markers that may explain why some people develop progressive multiple sclerosis, or MS. The study, led by researchers at OHSU in Portland, Oregon, and Yale University, point the way toward developing the first-ever treatment to prevent progressive forms of the disease.